文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

GRB2通过与mRNA结合调控SK-BR-3细胞中的整体表达和可变剪接谱,促进乳腺癌的恶性行为。

GRB2 Promotes Malignant Behaviors of Breast Cancer by Modulating the Global Expression and Alternative Splicing Profiles in SK-BR-3 Cells Through Binding mRNA.

作者信息

Liu Wei, Huang Yumian, Qiao Lei, Chong Le, Xia Luhua, Abudurehaman Aikeremu, Li Hongyu

机构信息

Department of Breast Internal Medicine, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China.

Department of Breast and Thyroid Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

出版信息

Cancer Med. 2025 May;14(10):e70905. doi: 10.1002/cam4.70905.


DOI:10.1002/cam4.70905
PMID:40384436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086363/
Abstract

PURPOSE: The flexible protein GRB2 interacts with HER1-4 on the cell surface and regulates the development of tumor cells; meanwhile, it is also an RBP that plays an important role in post-transcriptional regulation in eukaryotes, which affects every stage of mRNA synthesis, modification, splicing, and stabilization. Although some studies have found a connection between GRB2 and HER2-overexpression breast cancer, highlighting the potential of GRB2 as a novel biomarker that stimulates tumor growth, limited data were available to elaborate on their interaction mechanisms. METHODS: In this research, we found 396 different gene expressions between the Grb2-knockdown group and the SK-BR-3 group by the RNA sequencing approach. After GRB2 was knocked down, 956 alternative splicing events occurred. RESULTS: The fRIP-seq results showed that GRB2-binding reads were significantly enriched in the intron region, indicating that UUAGC and UUGGUUGG might be the binding motifs. An integration analysis of DEGs with the peak genes of fRIP-seq revealed that 63 genes possess GRB2 binding sites on their mRNAs or antisense RNAs. By integration analysis of AS events with the peak genes of fRIP-seq, 66 genes related to AS events were found. CONCLUSIONS: Above, these AS events may be regulated by GRB2 to promote the progression of HER2-overexpression breast cancer.

摘要

目的:柔性蛋白GRB2在细胞表面与HER1 - 4相互作用并调节肿瘤细胞的发展;同时,它也是一种RNA结合蛋白(RBP),在真核生物的转录后调控中发挥重要作用,影响mRNA合成、修饰、剪接和稳定的各个阶段。尽管一些研究发现GRB2与HER2过表达乳腺癌之间存在联系,凸显了GRB2作为刺激肿瘤生长的新型生物标志物的潜力,但关于它们相互作用机制的详细数据却很有限。 方法:在本研究中,我们通过RNA测序方法发现Grb2基因敲低组和SK - BR - 3组之间存在396种不同的基因表达。GRB2基因敲低后,发生了956个可变剪接事件。 结果:fRIP - seq结果显示,GRB2结合读数在内含子区域显著富集,表明UUAGC和UUGGUUGG可能是结合基序。对差异表达基因(DEGs)与fRIP - seq峰值基因的整合分析表明,有63个基因在其mRNA或反义RNA上具有GRB2结合位点。通过对可变剪接(AS)事件与fRIP - seq峰值基因的整合分析,发现了66个与AS事件相关的基因。 结论:综上所述,这些可变剪接事件可能受GRB2调控,以促进HER2过表达乳腺癌的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/3161815b882f/CAM4-14-e70905-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/08f550056881/CAM4-14-e70905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/36672955e68a/CAM4-14-e70905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/76898d099aa0/CAM4-14-e70905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/7040f6fa0c98/CAM4-14-e70905-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/e56fce8b114e/CAM4-14-e70905-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/ff7cc567d1fd/CAM4-14-e70905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/3161815b882f/CAM4-14-e70905-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/08f550056881/CAM4-14-e70905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/36672955e68a/CAM4-14-e70905-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/76898d099aa0/CAM4-14-e70905-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/7040f6fa0c98/CAM4-14-e70905-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/e56fce8b114e/CAM4-14-e70905-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/ff7cc567d1fd/CAM4-14-e70905-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5730/12086363/3161815b882f/CAM4-14-e70905-g007.jpg

相似文献

[1]
GRB2 Promotes Malignant Behaviors of Breast Cancer by Modulating the Global Expression and Alternative Splicing Profiles in SK-BR-3 Cells Through Binding mRNA.

Cancer Med. 2025-5

[2]
GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway.

Sci Rep. 2025-4-27

[3]
miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.

Biochem Biophys Res Commun. 2016-8-5

[4]
The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.

J Biol Chem. 2014-1-9

[5]
KHSRP has oncogenic functions and regulates the expression and alternative splicing of DNA repair genes in breast cancer MDA-MB-231 cells.

Sci Rep. 2024-6-26

[6]
A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro.

Int J Oncol. 2013-1-10

[7]
PAIP1 binds to pre-mRNA and regulates alternative splicing of cancer pathway genes including VEGFA.

BMC Genomics. 2024-10-3

[8]
Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells.

Cells. 2021-4-9

[9]
HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.

Oncogene. 2012-10-1

[10]
MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.

BMC Cancer. 2014-11-24

本文引用的文献

[1]
A developmental constraint model of cancer cell states and tumor heterogeneity.

Cell. 2024-6-6

[2]
ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway.

Biochem Genet. 2024-5-9

[3]
CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake.

Elife. 2024-5-7

[4]
Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.

J Transl Med. 2023-10-14

[5]
RING induces cell cycle arrest and apoptosis in human breast cancer cells by regulating the HSF1/MT2A axis.

Exp Cell Res. 2023-12-1

[6]
Clinical implications and immune features of CENPN in breast cancer.

BMC Cancer. 2023-9-11

[7]
GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights.

Front Oncol. 2023-8-18

[8]
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries.

Asia Pac J Clin Oncol. 2023-12

[9]
Cancer statistics, 2023.

CA Cancer J Clin. 2023-1

[10]
Role of DEK in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review.

Crit Rev Oncol Hematol. 2023-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索